Target intelligence / Profile preview

Lymphatic vessel endothelial hyaluronic acid receptor 1 (LYVE-1)

Target
LYVE-1
Molecular classification
Receptor, Type I integral membrane glycoprotein, Member of the Link protein superfamily
01

Overview

Lymphatic vessel endothelial hyaluronic acid receptor 1 (LYVE-1) is a type I integral membrane glycoprotein and a member of the Link protein superfamily. It functions as a receptor for hyaluronan (hyaluronic acid), binding both soluble and immobilized forms of this glycosaminoglycan. LYVE-1 is highly and specifically expressed on the surface of lymphatic endothelium and lymph node sinuses, which has made it a widely used marker for identifying lymphatic vessels in both normal and disease contexts. Its functions include possible roles in hyaluronan uptake, lymphatic hyaluronan transport, immune cell trafficking (especially dendritic cells and leukocytes), and potentially serving as a docking receptor during cell transmigration. Despite its specificity and abundance on lymphatics, genetic knockout studies in mice show no essential requirement for LYVE-1 in development, lymphatic function, or immune cell trafficking under physiological conditions, suggesting redundancy or compensation by other molecules. However, LYVE-1 may play more specialized roles in pathologic settings, such as during tumor metastasis and certain inflammatory responses

Other names
LYVE-1Lymphatic vessel endothelial hyaluronan receptor 1
02

Mechanism of action

Not established for drugs as there are no approved drugs known to act directly through LYVE-1. For molecular mechanisms: mediates binding and internalization of hyaluronan, potentially involved in the transmigration of hyaluronan-presenting immune cells

03

Biological functions

Hyaluronan (hyaluronic acid) bindingLymphatic hyaluronan transportCell adhesion and transmigration (e.g., for dendritic cells and leukocytes)Immune cell traffickingMolecular marker for lymphatic endotheliumPossible involvement in tumor metastasis
04

Disease associations

Cancer (tumor metastasis and lymphangiogenesis)Inflammation (immune cell recruitment and trafficking)Other (studies have not shown profound developmental or immune defects in knockout mice, indicating any additional disease role may be context-specific)
05

Safety considerations

Not established; LYVE-1 knockout mice show normal development and physiology, suggesting that inhibiting LYVE-1 function may have minimal direct toxicity, but implications for immune modulation or tissue injury/repair remain insufficiently characterized
06

Interacting drugs

None specifically identified in current literature; LYVE-1 is not a routine direct therapeutic target for any approved drugs as of this writing
07

Biomarkers

Marker for lymphatic endothelial cellsUsed as a biomarker of lymphangiogenesis in cancer and inflammatory conditions

Beyond the preview

Go deeper on Lymphatic vessel endothelial hyaluronic acid receptor 1 (LYVE-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lymphatic vessel endothelial hyaluronic acid receptor 1 (LYVE-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call